SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (1474)2/3/1997 4:32:00 PM
From: Richard Mazzarella   of 4342
 
Robin, I was wondering (dangerous?) if PRLN had ever tested AndroCar as a prophylactic to minimize getting cancer. I would think that a known carcinogen could be applied in vitro with AndroCar and observe the effect against a control. Then they could go in vivo (mice) and see if they get a similar result. Some people will never give up tobacco no matter how educated they are about risks. If the tests are positive, I hypothesize a new product. Bundle AndroCar with tobacco products; just kidding, but there may be an application here for high risk carcinogen exposure. Either, to be used if the exposure could not be eliminated or after an exposure. What do you or anyone think? Maybe I should stop wondering and just go back to buying and selling stocks?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext